292 related articles for article (PubMed ID: 26483471)
1. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters.
Barr JJ; Auro R; Sam-Soon N; Kassegne S; Peters G; Bonilla N; Hatay M; Mourtada S; Bailey B; Youle M; Felts B; Baljon A; Nulton J; Salamon P; Rohwer F
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13675-80. PubMed ID: 26483471
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage adhering to mucus provide a non-host-derived immunity.
Barr JJ; Auro R; Furlan M; Whiteson KL; Erb ML; Pogliano J; Stotland A; Wolkowicz R; Cutting AS; Doran KS; Salamon P; Youle M; Rohwer F
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10771-6. PubMed ID: 23690590
[TBL] [Abstract][Full Text] [Related]
3. Relevance of the bacteriophage adherence to mucus model for
Almeida GMdF; Ravantti J; Grdzelishvili N; Kakabadze E; Bakuradze N; Javakhishvili E; Megremis S; Chanishvili N; Papadopoulos N; Sundberg L-R
Microbiol Spectr; 2024 Jun; ():e0352023. PubMed ID: 38912817
[No Abstract] [Full Text] [Related]
4. Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria.
Almeida GMF; Laanto E; Ashrafi R; Sundberg LR
mBio; 2019 Nov; 10(6):. PubMed ID: 31744913
[TBL] [Abstract][Full Text] [Related]
5. Innate and acquired bacteriophage-mediated immunity.
Barr JJ; Youle M; Rohwer F
Bacteriophage; 2013 Jul; 3(3):e25857. PubMed ID: 24228227
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage defends murine gut from Escherichia coli invasion via mucosal adherence.
Wu J; Fu K; Hou C; Wang Y; Ji C; Xue F; Ren J; Dai J; Barr JJ; Tang F
Nat Commun; 2024 Jun; 15(1):4764. PubMed ID: 38834561
[TBL] [Abstract][Full Text] [Related]
7. Impact of bacteria motility in the encounter rates with bacteriophage in mucus.
Joiner KL; Baljon A; Barr J; Rohwer F; Luque A
Sci Rep; 2019 Nov; 9(1):16427. PubMed ID: 31712565
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophages evolve enhanced persistence to a mucosal surface.
Chin WH; Kett C; Cooper O; Müseler D; Zhang Y; Bamert RS; Patwa R; Woods LC; Devendran C; Korneev D; Tiralongo J; Lithgow T; McDonald MJ; Neild A; Barr JJ
Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2116197119. PubMed ID: 35767643
[TBL] [Abstract][Full Text] [Related]
9. T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo.
Pett N; Hunter M; Carranza García NA; Seo JH; Collins SR; Rohwer F; Osborne LC; Tropini C
J Vis Exp; 2024 Jan; (203):. PubMed ID: 38345223
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?
Ling KM; Stick SM; Kicic A
Front Med (Lausanne); 2023; 10():1088494. PubMed ID: 37265479
[TBL] [Abstract][Full Text] [Related]
11. Manipulating Interactions between T4 Phage Long Tail Fibers and Escherichia coli Receptors.
Suga A; Kawaguchi M; Yonesaki T; Otsuka Y
Appl Environ Microbiol; 2021 Jun; 87(13):e0042321. PubMed ID: 33893116
[TBL] [Abstract][Full Text] [Related]
12. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.
Weiss M; Denou E; Bruttin A; Serra-Moreno R; Dillmann ML; Brüssow H
Virology; 2009 Oct; 393(1):16-23. PubMed ID: 19699505
[TBL] [Abstract][Full Text] [Related]
13. Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.
Chibani-Chennoufi S; Sidoti J; Bruttin A; Dillmann ML; Kutter E; Qadri F; Sarker SA; Brüssow H
J Bacteriol; 2004 Dec; 186(24):8287-94. PubMed ID: 15576777
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
[TBL] [Abstract][Full Text] [Related]
15. A physiological role for tRNA nucleotidyltransferase during bacteriophage infection.
Morse JW; Deutscher MP
Biochem Biophys Res Commun; 1976 Dec; 73(4):953-9. PubMed ID: 15625866
[TBL] [Abstract][Full Text] [Related]
16. Effects of environmental and clinical interferents on the host capture efficiency of immobilized bacteriophages.
Dixon DV; Hosseinidoust Z; Tufenkji N
Langmuir; 2014 Mar; 30(11):3184-90. PubMed ID: 24617341
[TBL] [Abstract][Full Text] [Related]
17. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
18. Phage adsorption to bacteria in the light of the electrostatics: a case study using E. coli, T2 and flow cytometry.
Zemb O; Manefield M; Thomas F; Jacquet S
J Virol Methods; 2013 May; 189(2):283-9. PubMed ID: 23499611
[TBL] [Abstract][Full Text] [Related]
19. Immobilization of Active Bacteriophages on Polyhydroxyalkanoate Surfaces.
Wang C; Sauvageau D; Elias A
ACS Appl Mater Interfaces; 2016 Jan; 8(2):1128-38. PubMed ID: 26741170
[TBL] [Abstract][Full Text] [Related]
20. Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms.
Coulter LB; McLean RJ; Rohde RE; Aron GM
Viruses; 2014 Oct; 6(10):3778-86. PubMed ID: 25285538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
